Kivu Bioscience Funding & Investors

San Francisco, CA

Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets.

kivubioscience.com

Total Amount Raised: $92,000,000

Kivu Bioscience Funding Rounds

Series A
$92,000,000
Oct 27, 2024
Series A Investors
Novo Holdings
BOM
BGV (BioGeneration Ventures)
Red Tree Venture Capital
Gimv
M Ventures
HEALTHCAP

Funding info provided by Diffbot.